Guggenheim Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Guggenheim Capital’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-34,298	Closed	-$3.33M	–	2219
2019 Q3	$3.33M	Sell	34,298 -1,545	-4%	-$155K	0.03%	796
2019 Q2	$3.67M	Buy	35,843 +2,983	+9%	+$322K	0.03%	763
2019 Q1	$3.74M	Sell	32,860 -11,086	-25%	-$815K	0.03%	769
2018 Q4	$1.72M	Sell	43,946 -5,123	-10%	-$222K	0.01%	1119
2018 Q3	$2.68M	Buy	49,069 +7,113	+17%	+$486K	0.02%	1073
2018 Q2	$3.47M	Sell	41,956 -4,627	-10%	-$357K	0.02%	924
2018 Q1	$3.1M	Sell	46,583 -17,636	-27%	-$1.02M	0.01%	1329
2017 Q4	$3.3M	Buy	64,219 +12,823	+25%	+$921K	0.01%	1285
2017 Q3	$4.58M	Buy	51,396 +3,159	+7%	+$240K	0.01%	1121
2017 Q2	$2.88M	Buy	48,237 +1,581	+3%	+$88.3K	0.01%	1355
2017 Q1	$2.49M	Sell	46,656 -1,704	-4%	-$101K	0.01%	1492
2016 Q4	$2.41M	Buy	+48,360	New	+$2.59M	0.01%	1527

Guggenheim Capital's ONCE Position: Q4 2019 in Review

Guggenheim Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 34,298 shares — an estimated $3.33M sold.

Guggenheim Capital first reported a position in ONCE in Q4 2016 and held it in 12 quarters. The position peaked at $4.58M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Guggenheim Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Guggenheim Capital sold 34,298 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $3.33M.
Guggenheim Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2016 and held it in 12 quarters.
Guggenheim Capital's Spark Therapeutics, Inc. Common Stock position peaked at $4.58M in Q3 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Guggenheim Capital's 13F filing for Q4 2019, filed 14 Feb 2020.